Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

GF58877948

Beryllium

wire reel, 0.1m, diameter 0.356mm, annealed and clean, 99.7%

Synonym(s):

Beryllium, BE005120, Glucinium

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
Be
CAS Number:
7440-41-7
Molecular Weight:
9.01
MDL number:
MFCD00134032
UNSPSC Code:
12141501
PubChem Substance ID:
329808880
NACRES:
NA.23

Assay

99.7%

form

wire

autoignition temp.

1198 °F

manufacturer/tradename

Goodfellow 588-779-48

resistivity

4.46 μΩ-cm, 20°C

L × diam.

0.1 m × 0.356 mm

bp

2970 °C (lit.)

mp

1278 °C (lit.)

density

1.85 g/mL at 25 °C (lit.)

SMILES string

[Be]

InChI

1S/Be

InChI key

ATBAMAFKBVZNFJ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Oral - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kristin J Cummings et al.
Environmental health perspectives, 117(8), 1250-1256 (2009-08-13)
Although chronic beryllium disease (CBD) is clearly an immune-mediated granulomatous reaction to beryllium, acute beryllium disease (ABD) is commonly considered an irritative chemical phenomenon related to high exposures. Given reported new cases of ABD and projected increased demand for beryllium
Richard T Sawyer et al.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 24(1), 1-17 (2010-10-29)
During the last decade, there have been concerted efforts to reduce beryllium (Be) exposure in the workplace and thereby reduce potential cases of this occupational lung disorder. Despite these efforts, it is estimated that there are at least one million
D M Hollins et al.
Critical reviews in toxicology, 39 Suppl 1, 1-32 (2009-11-13)
The potential carcinogenicity of beryllium has been a topic of study since the mid-1940s. Since then, numerous scientific and regulatory bodies have assigned beryllium to various categories with respect to its carcinogenicity. Past epidemiologic and animal studies, however, have been
A Seidler et al.
Occupational medicine (Oxford, England), 62(7), 506-513 (2012-06-19)
The relevance of beryllium sensitization testing for occupational health practice and prevention is unclear. To analyse the natural course of beryllium sensitization and clarify the prognosis following cessation of exposure among sensitized workers. An electronic literature search was conducted in
T Mark McCleskey et al.
Journal of occupational and environmental hygiene, 6(12), 751-757 (2009-11-07)
We compare beryllium to H+ and show that beryllium can displace H+ in many "strong hydrogen bonds" where Be as a "tetrahedral proton" (O-Be-O angle is tetrahedral as opposed to the nearly linear O-H-O angle) is thermodynamically preferred. The strong
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service